These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12964317)

  • 21. Identifying and managing arterial ulceration.
    Hampton S
    Community Nurse; 2000 Aug; 6(7):49-52. PubMed ID: 11982089
    [No Abstract]   [Full Text] [Related]  

  • 22. Surgical treatment of pyoderma gangrenosum with negative pressure wound therapy and split thickness skin grafting under adequate immunosuppression is a valuable treatment option: Case series of 15 patients.
    Pichler M; Larcher L; Holzer M; Exler G; Thuile T; Gatscher B; Tappeiner L; Deluca J; Carriere C; Nguyen VA; Moosbrugger-Martinz V; Schmuth M; Klein GF; Eisendle K
    J Am Acad Dermatol; 2016 Apr; 74(4):760-5. PubMed ID: 26979359
    [No Abstract]   [Full Text] [Related]  

  • 23. Rare complication after cardiac surgery: a case report of pyoderma gangrenosum.
    Mariscalco G; Piffaretti G; Ferrarese S; Tozzi M; Cattaneo P; Sala A
    J Card Surg; 2009; 24(1):93-7. PubMed ID: 18793230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring debridement options for chronic venous leg ulcers.
    Davies CE; Turton G; Woolfrey G; Elley R; Taylor M
    Br J Nurs; 2005 Apr 14-27; 14(7):393-7. PubMed ID: 15924016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective strategies for the management of pyoderma gangrenosum: a comprehensive review.
    Patel F; Fitzmaurice S; Duong C; He Y; Fergus J; Raychaudhuri SP; Garcia MS; Maverakis E
    Acta Derm Venereol; 2015 May; 95(5):525-31. PubMed ID: 25387526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathergic pyoderma gangrenosum in a venous ulcer.
    Rosina P; Cunego S; Franz CZ; D'Onghia FS; Chieregato G
    Int J Dermatol; 2002 Mar; 41(3):166-7. PubMed ID: 12010342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic foot ulcer management using maggot debridement and topical negative pressure therapy.
    Brin YS; Mumcuoglu KY; Massarwe S; Wigelman M; Gross E; Nyska M
    J Wound Care; 2007 Mar; 16(3):111-3. PubMed ID: 17385586
    [No Abstract]   [Full Text] [Related]  

  • 28. Pustular pyoderma gangrenosum.
    Leger M; Newlove T; Chu J; Meehan S; Stein J
    Dermatol Online J; 2011 Oct; 17(10):17. PubMed ID: 22031643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyoderma gangrenosum: a misdiagnosis.
    El-Kehdy J; Haneke E; Karam PG
    J Drugs Dermatol; 2013 Feb; 12(2):228-30. PubMed ID: 23377399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyoderma gangrenosum and leg ulcers associated with vasculitis: importance of addressing the underlying disease process when treating inflammatory wounds.
    Burch J; Jones M
    J Wound Ostomy Continence Nurs; 2006; 33(1):77-81; discussion 81-2. PubMed ID: 16444109
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of a protease-modulating matrix dressing on a non-healing tendo-Achilles surgical wound.
    Noble T
    J Wound Care; 2006 Sep; 15(8):368-71. PubMed ID: 17001947
    [No Abstract]   [Full Text] [Related]  

  • 32. Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression.
    de Imus G; Golomb C; Wilkel C; Tsoukas M; Nowak M; Falanga V
    J Am Acad Dermatol; 2001 Jan; 44(1):61-6. PubMed ID: 11148478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pyoderma gangrenosum: a rare pathology or an omitted diagnosis?].
    Lê Huu S; Spertini F; Roggero P; Egloff DV; Raffoul W
    Ann Chir Plast Esthet; 2009 Feb; 54(1):82-7. PubMed ID: 18938011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An unexpected effect of Dermacyn on infected leg ulcers.
    Steenvoorde P; van Doorn LP; Jacobi CE; Oskam J
    J Wound Care; 2007 Feb; 16(2):60-1. PubMed ID: 17319619
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pyoderma gangrenosum, an etiology of chronic ulcer disregarded?].
    Zaugg P; Koch N; Erba P; Raffoul W
    Rev Med Suisse; 2016 Feb; 12(505):318-21. PubMed ID: 27039446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pyoderma gangrenosum--clinical, laboratory and therapeutic approaches. Review of 28 cases].
    Duarte AF; Nogueira A; Lisboa C; Azevedo F
    Dermatol Online J; 2009 Jul; 15(7):3. PubMed ID: 19903431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A team approach to wound care in pyoderma gangrenosum.
    Sutherland MA
    J Wound Care; 1997 Apr; 6(4):161-4. PubMed ID: 9256713
    [No Abstract]   [Full Text] [Related]  

  • 38. Intractable wounds caused by pyoderma gangrenosum in a patient with critical limb ischemia treated with cyclosporine and adjuvant sympathectomy.
    Takahashi Y; Yamaguchi Y; Itoh K; Sano S; Morita A; Katayama I
    Dermatol Surg; 2009 Apr; 35(4):699-703. PubMed ID: 19309343
    [No Abstract]   [Full Text] [Related]  

  • 39. Managing pyoderma gangrenosum: a synergistic approach combining surgical débridement, vacuum-assisted closure, and hyperbaric oxygen therapy.
    Niezgoda JA; Cabigas EB; Allen HK; Simanonok JP; Kindwall EP; Krumenauer J
    Plast Reconstr Surg; 2006 Feb; 117(2):24e-28e. PubMed ID: 16462310
    [No Abstract]   [Full Text] [Related]  

  • 40. A randomized controlled trial of larval therapy for the debridement of leg ulcers: results of a multicenter, randomized, controlled, open, observer blind, parallel group study.
    Mudge E; Price P; Walkley N; Harding KG
    Wound Repair Regen; 2014; 22(1):43-51. PubMed ID: 24299513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.